Self-replication

3D Systems and CollPlant Enter Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments

Retrieved on: 
Tuesday, June 22, 2021

Using 3D bioprinting, these matrices can be designed to match the patients anatomy to support the breast implant.

Key Points: 
  • Using 3D bioprinting, these matrices can be designed to match the patients anatomy to support the breast implant.
  • Through this co-development agreement, 3D Systems and CollPlant with combined expertise in 3D printing, healthcare, bioprinting and bioinks will develop 3D bioprinted soft tissue matrices using rhCollagen.
  • Through this project were embarking on with CollPlant, were exploring a novel application that could offer a new reconstruction treatment for breast cancer survivors.
  • More than 30 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing industry.

ISAE-SUPAERO's "Collaborative Rover and Drone" Project, Facilitating the Exploration of the Moon

Retrieved on: 
Monday, June 21, 2021

But before being able to settle on the Moon in a prolonged way to exploit its resources or as a logistic support for future exploration missions further away, an exploration work is necessary.

Key Points: 
  • But before being able to settle on the Moon in a prolonged way to exploit its resources or as a logistic support for future exploration missions further away, an exploration work is necessary.
  • The use of autonomous robotic systems would allow mapping of dangerous or hard-to-reach areas from space, before eventually deploying infrastructure such as a spaceport or human habitation.
  • Thanks to the cartography made by the drone, the rover is able to choose the shortest path and to determine the possible obstacles, which allows to shorten each exploration mission.
  • In the perspective of a lunar installation, the robots would intervene in support of critical activities.

MeaTech Announces Filing of Provisional Patent Application for Novel Bioprinting Method

Retrieved on: 
Thursday, June 3, 2021

The patent application is directed to a novel method for bioprinting that MeaTech believes has the potential to provide exceptional control of bioink printing during multi-layered bioprinting process.

Key Points: 
  • The patent application is directed to a novel method for bioprinting that MeaTech believes has the potential to provide exceptional control of bioink printing during multi-layered bioprinting process.
  • MeaTech believes these attributes could allow for bioprinting resolutions that are highly advantageous in achieving premium, thick meat emulating products.
  • The filing of this provisional patent application directly relates to MeaTech's cellular agriculture 3D bioprinting goals to produce premium cuts of (animal) cell-based cuts of meat.
  • To date, MeaTech has a portfolio of six provisional and non-provisional patent applications with the USPTO and World Intellectual Property Organization (WIPO) filed through the PCT.

$3.26 Billion 3D Bioprinting Market, 2027 by Technology (Inkjet, Magnetic Levitation, Laser-assisted), Component (3D Bioprinters, Biomaterials, Scaffolds), Material, Application - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 22, 2021

b'The "3D Bioprinting Market, By Technology (Inkjet Bioprinting, Magnetic Levitation Bioprinting, Laser-assisted Bioprinting), Component (3D Bioprinters, Biomaterials, Scaffolds), Material, Application and Geography - Global Forecast to 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe 3D Bioprinting Market size is projected to reach USD 3261.31 Mn by 2027, from USD 796.9 Mn in 2020 growing at a CAGR of 22.3% during 2021-2027.\nThe 3D bioprinting market research report provides an in-depth overview of the industry including market segmentation by technology, component, material, application and geography.

Key Points: 
  • b'The "3D Bioprinting Market, By Technology (Inkjet Bioprinting, Magnetic Levitation Bioprinting, Laser-assisted Bioprinting), Component (3D Bioprinters, Biomaterials, Scaffolds), Material, Application and Geography - Global Forecast to 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe 3D Bioprinting Market size is projected to reach USD 3261.31 Mn by 2027, from USD 796.9 Mn in 2020 growing at a CAGR of 22.3% during 2021-2027.\nThe 3D bioprinting market research report provides an in-depth overview of the industry including market segmentation by technology, component, material, application and geography.
  • The report also profiles all major companies active in this field.\n3D Bioprinting market is segmented by region and further by countries, technology, component, material, and application.
  • Players, stakeholders, and other participants in the global 3D bioprinting market will be able to gain a strong position as this report will surely benefit their marketing strategies.
  • Also, it splits 3D bioprinting market segmentation by technology, component, material, application and region to deep dive research and reveals market profile and prospects.\n'

3D Bioprinting of Living Human Tissues/Organs Market is growing by leaps and bounds with Top Key players like 3Dynamic Systems, Aspect Biosystems, Allevi, BioDan | UnivDatos Market Insights

Retrieved on: 
Wednesday, April 7, 2021

The 3D Bioprinting of Living Human Tissues report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities.

Key Points: 
  • The 3D Bioprinting of Living Human Tissues report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities.
  • This innovative report makes use of several analyses to get a closer outlook on the 3D Bioprinting of Living Human Tissues/Organs market.
  • The 3D Bioprinting of Living Human Tissues report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the 3D Bioprinting of Living Human Tissues at the global and regional levels.

3D Bioprinting of Living Human Tissues/Organs Market is growing by leaps and bounds with Top Key players like 3Dynamic Systems, Aspect Biosystems, Allevi, BioDan | UnivDatos Market Insights

Retrieved on: 
Wednesday, April 7, 2021

The 3D Bioprinting of Living Human Tissues report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities.

Key Points: 
  • The 3D Bioprinting of Living Human Tissues report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities.
  • This innovative report makes use of several analyses to get a closer outlook on the 3D Bioprinting of Living Human Tissues/Organs market.
  • The 3D Bioprinting of Living Human Tissues report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the 3D Bioprinting of Living Human Tissues at the global and regional levels.

Terradepth Announces Results of Phase 1 Underwater Autonomous Submarine Trials to Map the Earth’s Oceans

Retrieved on: 
Thursday, March 18, 2021

Terradepth , a disruptor in maritime data collection and use, today announced the successful completion of its Phase 1 trials.

Key Points: 
  • Terradepth , a disruptor in maritime data collection and use, today announced the successful completion of its Phase 1 trials.
  • The Phase 1 test results conclusively demonstrate that the companys unmanned submersible could collect and process underwater data, understand features of import, and automatically retask itself with no human intervention.
  • View the full release here: https://www.businesswire.com/news/home/20210318005135/en/
    Terradepths mission is to increase ocean knowledge through autonomous, high-resolution, scalable data collection and a radically improved data experience.
  • The company is applying autonomous robotics, AI/ML, and the latest software concepts and methodologies to create the world's first deep ocean data-as-a-service business.

CollPlant Issues Letter to Shareholders

Retrieved on: 
Thursday, February 18, 2021

REHOVOT,Israel, Feb. 18, 2021 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ:CLGN) today announced the following letter from its Chief Executive Officer,Yehiel Tal, to its shareholders.

Key Points: 
  • REHOVOT,Israel, Feb. 18, 2021 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ:CLGN) today announced the following letter from its Chief Executive Officer,Yehiel Tal, to its shareholders.
  • Despite the difficulties arising from the pandemic, we advanced several activities in 2020 making it a transformational year for CollPlant Biotechnologies.
  • We expanded our collaboration with United Therapeutics which exercised its option with CollPlant to cover a second lifesaving organ, human kidneys, in addition to lungs.
  • As members of the ARMI consortium, CollPlant contributes its expertise in BioInks for 3D bioprinting of tissues and organs.

Verizon enters into agreement to acquire autonomous mobile robot software company, incubed IT

Retrieved on: 
Monday, February 15, 2021

Mobile robot orchestration is a real and emerging challenge faced by enterprises today.

Key Points: 
  • Mobile robot orchestration is a real and emerging challenge faced by enterprises today.
  • By integrating incubed ITs autonomous software with Verizons 5G platform, we will have the ability to power robotic automation at scale.
  • Upon closing and as Verizon continues to expand its 5G coverage, capacity, and mobile edge compute capabilities, incubed ITs autonomous software will enable enterprise customers to gain new efficiencies as they scale their autonomous mobile robot fleets.
  • incubed ITs award-winning software enables robots to localize and navigate autonomously and can be easily integrated into nearly any mobile robot.

CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares

Retrieved on: 
Friday, February 12, 2021

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

Key Points: 
  • H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
  • The gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses payable by the Company, are expected to be $35.0 million.
  • The ADSs are being offered by CollPlant pursuant to a "shelf" registration statement on Form F-3 (File No.
  • CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics.